MedPath

The feasibility study for screening of early stage of lung cancer by novel urinary biomarker using protein fragments: a prospective study

Not Applicable
Conditions
Idiopathic pulmonary fibrosis (IPF)
Registration Number
JPRN-UMIN000037033
Lead Sponsor
niversity of Miyazaki
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients who have abnormal shadow (more than or equal to 1.0 cm) clinicaly suspected lung cancer by high resolution CT. 2)Patients who have proteinuria, positive urine sugar or urine occult blood in urinalysis (more than or equal to 2+). 3)Patients who have renal dysfunction (Serum levels of creatinine > 2.0 mg/dl). 4)Patients who have alcohol or drug dependence or who are suspected to have alcohol or drug dependence. 5)Patients who is pregnant or who is suspected to be pregnant. 6)Patients who was enrolled another clinical trial and was prescribed a study drug within one month. 7)Patients whose attending physicians consider to be inappropriate for this study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath